144 related articles for article (PubMed ID: 8725734)
21. Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass.
Kaminishi Y; Hiramatsu Y; Watanabe Y; Yoshimura Y; Sakakibara Y
Ann Thorac Surg; 2004 Feb; 77(2):644-50. PubMed ID: 14759453
[TBL] [Abstract][Full Text] [Related]
22. Platelet composition and function in patients undergoing cardiopulmonary bypass for heart surgery.
Bertolino G; Locatelli A; Noris P; Maurelli M; Ceriana P; Mazzini G; Spedini P; Belletti S; Balduini CL
Haematologica; 1996; 81(2):116-20. PubMed ID: 8641638
[TBL] [Abstract][Full Text] [Related]
23. Low-dose and high-dose aprotinin improve hemostasis in coronary operations.
Speekenbrink RG; Wildevuur CR; Sturk A; Eijsman L
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):523-30. PubMed ID: 8751522
[TBL] [Abstract][Full Text] [Related]
24. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting.
Poston RS; White C; Gu J; Brown J; Gammie J; Pierson RN; Lee A; Connerney I; Avari T; Christenson R; Tandry U; Griffith BP
Ann Thorac Surg; 2006 Jan; 81(1):104-10; discussion 110-1. PubMed ID: 16368345
[TBL] [Abstract][Full Text] [Related]
25. Aprotinin combined with nitric oxide and prostaglandin E1 protects the canine kidney from cardiopulmonary bypass-induced injury.
Du L; Zhou J; Tang J; An Q; Lin K; Wu X; Tao K; Liu J
Eur J Cardiothorac Surg; 2010 Jul; 38(1):98-103. PubMed ID: 20188582
[TBL] [Abstract][Full Text] [Related]
26. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
[TBL] [Abstract][Full Text] [Related]
27. A single dose of aprotinin prevents platelet hyporeactivity after coronary artery bypass graft surgery.
Szczeklik W; Morawski W; Sanak M; Jakieła B; Bolkowski M; Cisowski M; Szczeklik M; Bochenek A; Musiał J
Pol Arch Med Wewn; 2010 Sep; 120(9):321-7. PubMed ID: 20864904
[TBL] [Abstract][Full Text] [Related]
28. Aprotinin reduces cardiopulmonary bypass-induced blood loss and inhibits fibrinolysis without influencing platelets.
Orchard MA; Goodchild CS; Prentice CR; Davies JA; Benoit SE; Creighton-Kemsford LJ; Gaffney PJ; Michelson AD
Br J Haematol; 1993 Nov; 85(3):533-41. PubMed ID: 7510990
[TBL] [Abstract][Full Text] [Related]
29. The influence of the duration of cardiopulmonary bypass on coagulation, fibrinolysis and platelet function.
Wahba A; Rothe G; Lodes H; Barlage S; Schmitz G
Thorac Cardiovasc Surg; 2001 Jun; 49(3):153-6. PubMed ID: 11432473
[TBL] [Abstract][Full Text] [Related]
30. Defining the role of aprotinin in heart transplantation.
Prendergast TW; Furukawa S; Beyer AJ; Eisen HJ; McClurken JB; Jeevanandam V
Ann Thorac Surg; 1996 Sep; 62(3):670-4. PubMed ID: 8783991
[TBL] [Abstract][Full Text] [Related]
31. Effects of minimal dose aprotinin on blood loss and fibrinolytic system-complement activation in coronary artery bypass grafting surgery.
Cicekcioglu F; Cagli K; Emir M; Topbas M; Catav Z; Sener E; Tasdemir O
J Card Surg; 2006; 21(4):336-41. PubMed ID: 16846409
[TBL] [Abstract][Full Text] [Related]
32. Pro: Aprotinin should be used in coronary artery bypass graft surgery with cardiopulmonary bypass.
Hill SE
J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):298-301. PubMed ID: 17418753
[No Abstract] [Full Text] [Related]
33. Aprotinin modulation of platelet activation in patients undergoing cardiopulmonary bypass operations.
Primack C; Walenga JM; Koza MJ; Shankey TV; Pifarre R
Ann Thorac Surg; 1996 Apr; 61(4):1188-93. PubMed ID: 8607681
[TBL] [Abstract][Full Text] [Related]
34. Comparison of early platelet activation in patients undergoing on-pump versus off-pump coronary artery bypass surgery.
Ballotta A; Saleh HZ; El Baghdady HW; Gomaa M; Belloli F; Kandil H; Balbaa Y; Bettini F; Bossone E; Menicanti L; Frigiola A; Bellucci C; Mehta RH
J Thorac Cardiovasc Surg; 2007 Jul; 134(1):132-8. PubMed ID: 17599498
[TBL] [Abstract][Full Text] [Related]
35. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting.
Lindvall G; Sartipy U; van der Linden J
Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456
[TBL] [Abstract][Full Text] [Related]
36. A randomized, controlled trial of aprotinin in neonates undergoing open-heart surgery.
Williams GD; Ramamoorthy C; Pentcheva K; Boltz MG; Kamra K; Reddy VM
Paediatr Anaesth; 2008 Sep; 18(9):812-9. PubMed ID: 18768040
[TBL] [Abstract][Full Text] [Related]
37. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
Vanek T; Jares M; Fajt R; Straka Z; Jirasek K; Kolesar M; Brucek P; Maly M
Eur J Cardiothorac Surg; 2005 Oct; 28(4):563-8. PubMed ID: 16125959
[TBL] [Abstract][Full Text] [Related]
38. High-dose aprotinin modulates the balance between proinflammatory and anti-inflammatory responses during coronary artery bypass graft surgery.
Tassani P; Augustin N; Barankay A; Braun SL; Zaccaria F; Richter JA
J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):682-6. PubMed ID: 11139109
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the effects of a cell saver and low-dose aprotinin on blood loss and homologous blood usage in patients undergoing valve surgery.
Tempe DK; Banerjee A; Virmani S; Mehta N; Panwar S; Tomar AS; Ghambeer DK; Nigam M
J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):326-30. PubMed ID: 11426363
[TBL] [Abstract][Full Text] [Related]
40. Activation of fibrinolysis in the pericardial cavity after cardiopulmonary bypass.
Khalil PN; Ismail M; Kalmar P; von Knobelsdorff G; Marx G
Thromb Haemost; 2004 Sep; 92(3):568-74. PubMed ID: 15351853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
